{"title":"Vimentin intermediate filaments facilitate transportation of hepatitis C virus components","authors":"Yifan Xing , Shuzhi Cui , Xinyi Huang , Weisong Zhao , Haoyu Li , Jing Zhao , Wakam Chang , Shuangshuang Zhao , Jin Zhong , Yuxin Chen , Yaming Jiu","doi":"10.1016/j.ejcb.2025.151505","DOIUrl":null,"url":null,"abstract":"<div><div>Vimentin, an intermediate filament protein, primarily contributes to intracellular organization, cell migration, and signal transduction. In recent years, the role of intermediate filaments in viral infection has garnered increasing attention. During viral infection, vimentin can regulate viral propagation by forming a vimentin cage to enclose viral replication factories, and facilitating the intracellular transport of viral components. However, whether vimentin can facilitate cell-to-cell transfer of viral components remains unknown. In this study, using hepatitis C virus (HCV) as a viral model, we demonstrated that HCV infection does not induce large-scale vimentin rearrangement or the formation of a vimentin cage. Interestingly, we observed that HCV components move directionally along a vimentin-containing cellular bridge from highly infected donor cells towards neighboring cells, potentially facilitating viral dissemination. Together, our findings unveil a previously unrecognized function of vimentin in the viral life cycle, expanding our understanding of the complex interplay between host cellular factors and viral strategies.</div></div>","PeriodicalId":12010,"journal":{"name":"European journal of cell biology","volume":"104 3","pages":"Article 151505"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of cell biology","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0171933525000305","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Vimentin, an intermediate filament protein, primarily contributes to intracellular organization, cell migration, and signal transduction. In recent years, the role of intermediate filaments in viral infection has garnered increasing attention. During viral infection, vimentin can regulate viral propagation by forming a vimentin cage to enclose viral replication factories, and facilitating the intracellular transport of viral components. However, whether vimentin can facilitate cell-to-cell transfer of viral components remains unknown. In this study, using hepatitis C virus (HCV) as a viral model, we demonstrated that HCV infection does not induce large-scale vimentin rearrangement or the formation of a vimentin cage. Interestingly, we observed that HCV components move directionally along a vimentin-containing cellular bridge from highly infected donor cells towards neighboring cells, potentially facilitating viral dissemination. Together, our findings unveil a previously unrecognized function of vimentin in the viral life cycle, expanding our understanding of the complex interplay between host cellular factors and viral strategies.
期刊介绍:
The European Journal of Cell Biology, a journal of experimental cell investigation, publishes reviews, original articles and short communications on the structure, function and macromolecular organization of cells and cell components. Contributions focusing on cellular dynamics, motility and differentiation, particularly if related to cellular biochemistry, molecular biology, immunology, neurobiology, and developmental biology are encouraged. Manuscripts describing significant technical advances are also welcome. In addition, papers dealing with biomedical issues of general interest to cell biologists will be published. Contributions addressing cell biological problems in prokaryotes and plants are also welcome.